Cerebrovascular Disease
General Principles
- Stroke is a medical emergency that requires rapid diagnosis and treatment. Remember that “TIME IS BRAIN.”
- The hallmark of stroke is acute interruption of cerebral blood flow to a specific brain region, resulting in a sudden-onset focal neurologic deficit.
- Fluctuation of functional deficits after stroke onset or a brief deficit known as TIA suggests tissue at risk for infarction that may be rescued by reestablishing and/or maintaining perfusion.
Epidemiology
More than 795,000 strokes occur per year in the US (one stroke every 40 seconds in the US population), and it is the fourth leading cause of death in the US (one death every 4 minutes).
Etiology
- Ischemic stroke can be subclassified into large artery atherothrombotic, small vessel, embolic, hypoperfusion, or hypercoagulable state (the latter being relatively rare).
- Atherothrombosis results from reduced flow within an artery or embolism of thrombus into the distal segment of an artery.
- Atherosclerosis is the most common etiology of thrombus formation in large vessels.
- Less common etiologies include dissection, fibromuscular dysplasia, moyamoya, and vasculitis.
- Small-vessel disease is due to lipohyalinosis, usually caused by hypertension.
- Cardioembolic strokes account for about 20% of all ischemic strokes. High-risk cardiac sources include atrial fibrillation/flutter, rheumatic valve disease, cardiac thrombus, cardiomyopathy, prosthetic valves, bacterial endocarditis, nonbacterial endocarditis (antiphospholipid antibody syndrome, marantic endocarditis, Libman–Sachs endocarditis), sick sinus syndrome, and coronary artery bypass graft surgery.
- Hypoperfusion occurs due to general circulatory problems and often results in bilateral symptoms. Infarction commonly occurs in border zones between large vessels resulting in watershed infarcts.
- Hypercoagulable states may predispose to arterial thrombosis. These include sickle cell disease, polycythemia vera, essential thrombocythemia, thrombotic thrombocytopenic purpura, antiphospholipid antibody syndrome, hyperhomocysteinemia, and others. Factor V Leiden, protein C and S deficiency, and antithrombin III deficiency typically result in venous, not arterial, infarcts.
- Atherothrombosis results from reduced flow within an artery or embolism of thrombus into the distal segment of an artery.
- Hemorrhagic stroke occurs in about 20% of all cases.
- The location of an intraparenchymal hemorrhage (IPH) may suggest its etiology.
- Deep hemorrhage in the basal ganglia, thalamus, or pons is often due to chronic systemic hypertension.
- Amyloid angiopathy typically causes peripheral lobar hemorrhages and is a common etiology in the elderly.
- Head trauma, anticoagulants, drugs (cocaine or amphetamines), arteriovenous malformation (AVM), tumor, blood dyscrasia, hemorrhagic conversion of an ischemic stroke, and vasculitis are other possible hemorrhagic stroke etiologies.
- Aneurysmal subarachnoid hemorrhage (for this section, SAH will refer to aneurysmal subarachnoid hemorrhage unless designated otherwise) is caused by the rupture of an arterial aneurysm resulting in bleeding into the subarachnoid space (which contains CSF). Hypertension, cigarette smoking, genetic factors, and septic emboli (resulting in mycotic aneurysms) can all contribute to aneurysm formation.
- The location of an intraparenchymal hemorrhage (IPH) may suggest its etiology.
- Cerebral venous sinus thrombosis (CVST) is the occlusion of a venous sinus by a thrombus. It occurs in hypercoagulable states such as late pregnancy or postpartum, cancer, and thrombophilias, as well as with trauma and adjacent inflammation/infection. It may manifest with ischemic infarcts and/or hemorrhage.
Risk Factors
Major significant risk factors for ischemic stroke include hypertension, prior TIA/stroke, carotid stenosis, diabetes mellitus, dyslipidemia, heart failure, cigarette smoking, alcohol consumption, oral contraceptive use, obesity, genetics, and age.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "Cerebrovascular Disease." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602041/all/Cerebrovascular_Disease.
Cerebrovascular Disease. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602041/all/Cerebrovascular_Disease. Accessed November 29, 2023.
Cerebrovascular Disease. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602041/all/Cerebrovascular_Disease
Cerebrovascular Disease [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 November 29]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602041/all/Cerebrovascular_Disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cerebrovascular Disease
ID - 602041
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602041/all/Cerebrovascular_Disease
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -